Diabetes medication may increase risk of perioperative ketoacidosis
Sodium-glucose cotransporter-2 inhibitors (SGLT2i), or gliflozins, are medications used in the treatment of type 2 diabetes mellitus (T2DM). They are designed to lower high blood glucose levels typical in T2DM, and work by ...
Apr 30, 2025
0
0